Mark Demitrack
Chief Tech/Sci/R&D Officer bei TREVENA, INC.
Vermögen: 16 882 $ am 31.03.2024
Profil
Mark A.
Demitrack currently works at Trevena, Inc., as Chief Medical Officer & Senior Vice President from 2018 and American College of Neuropsychopharmacology, as Member.
Dr. Demitrack also formerly worked at Lilly Research Laboratories, as Medical Director-New Antidepressant Team, Neuronetics, Inc., as Chief Medical Officer & Vice President from 2003 to 2017, Roivant Sciences Ltd., as Vice President-Clinical Strategy from 2017 to 2018, and Wyeth Pharmaceuticals, Inc., as Assistant Vice President-Global Medical Affairs.
Dr. Demitrack received his undergraduate degree from The Trustees of Columbia University in The City of New York and doctorate degree from Robert Wood Johnson Medical School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
TREVENA, INC.
0,20% | 09.02.2024 | 36 700 ( 0,20% ) | 16 882 $ | 31.03.2024 |
Aktive Positionen von Mark Demitrack
| Unternehmen | Position | Beginn |
|---|---|---|
| TREVENA, INC. | Chief Tech/Sci/R&D Officer | 21.05.2018 |
American College of Neuropsychopharmacology
 American College of Neuropsychopharmacology Miscellaneous Commercial ServicesCommercial Services The American College of Neuropsychopharmacology provides a range of resources related to psychopharmacology and related fields. The non-profit company is based in Brentwood, TN. The company's Neuropsychopharmacology Reviews publication offers authoritative and timely coverage of contemporary topics in the field. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Mark Demitrack
| Unternehmen | Position | Ende |
|---|---|---|
| ROIVANT SCIENCES LTD. | Corporate Officer/Principal | 01.05.2018 |
| NEURONETICS, INC. | Chief Tech/Sci/R&D Officer | 01.05.2017 |
Wyeth Pharmaceuticals, Inc.
 Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Corporate Officer/Principal | - |
Lilly Research Laboratories
 Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a private company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Corporate Officer/Principal | - |
Ausbildung von Mark Demitrack
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| Robert Wood Johnson Medical School | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| NEURONETICS, INC. | Health Technology |
| ROIVANT SCIENCES LTD. | Health Technology |
| TREVENA, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a private company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Commercial Services |
American College of Neuropsychopharmacology
American College of Neuropsychopharmacology Miscellaneous Commercial ServicesCommercial Services The American College of Neuropsychopharmacology provides a range of resources related to psychopharmacology and related fields. The non-profit company is based in Brentwood, TN. The company's Neuropsychopharmacology Reviews publication offers authoritative and timely coverage of contemporary topics in the field. | Commercial Services |
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Health Technology |
